1-3 of 3
Ellen Magenis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML

Clinical Trials & Observations
Michael E. O'Dwyer, Michael J. Mauro, Gwen Kurilik, Motomi Mori, Suzanne Balleisen, Susan Olson, Ellen Magenis, Renaud Capdeville, Brian J. Druker
Journal: Blood
Blood (2002) 100 (5): 1628–1633.
https://doi.org/10.1182/blood-2002-03-0777
Published: 2002
Journal Articles

Hematopathologic and cytogenetic findings in imatinib mesylate–treated chronic myelogenous leukemia patients: 14 months' experience

Clinical Trials & Observations
Rita M. Braziel, Teresa M. Launder, Brian J. Druker, Susan B. Olson, R. Ellen Magenis, Michael J. Mauro, Charles L. Sawyers, Ronald L. Paquette, Michael E. O'Dwyer
Journal: Blood
Blood (2002) 100 (2): 435–441.
https://doi.org/10.1182/blood.V100.2.435
Published: 2002
Journal Articles

DNA Cross-Linker–Induced G2/M Arrest in Group C Fanconi Anemia Lymphoblasts Reflects Normal Checkpoint Function

Michael C. Heinrich, Maureen E. Hoatlin, Amy J. Zigler, Kirsten V. Silvey, Antony C. Bakke, Winifred W. Keeble, Yu Zhi, Carol A. Reifsteck, Markus Grompe, Michael G. Brown, R. Ellen Magenis, Susan B. Olson, Grover C. Bagby, Jr
Journal: Blood
Blood (1998) 91 (1): 275–287.
https://doi.org/10.1182/blood.V91.1.275
Published: 1998